Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection-Reference-Cited by-同舟云学术

Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection

Published:2018-02-20 Issue:10 Volume:24 Page:2342-2349
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Heck Matthias M.,Retz Margitta,Bandur Miriam,Souchay Marc,Vitzthum Elisabeth,Weirich Gregor,Schuster Tibor,Autenrieth Michael,Kübler Hubert,Maurer Tobias,Thalgott Mark,Herkommer Kathleen,Gschwend Jürgen E.,Nawroth Roman

Funder

German Wilhelm-Sander Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Role of Lymph Node Dissection for High-Risk Localized Prostate Cancer Patients: A Population-Based, Retrospective Cohort Study;Indian Journal of Surgery;2024-09-06

2. Case Report: Analysis of four cases of metastatic bladder masses after radical prostatectomy;Frontiers in Oncology;2023-07-28

3. Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy;European Urology Open Science;2022-10

4. Selecting lymph node–positive patients for adjuvant therapy after radical prostatectomy and extended pelvic lymphadenectomy: An outcome analysis of 100 node-positive patients managed without adjuvant therapy;Current Urology;2022-09-09

5. Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer;Biomedicines;2021-09-15